Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Clinical Diagnostics Service – Kidney Disease The Clinical Diagnostics Service of the MORL is a Joint Commission-approved CLIAaccredited diagnostic laboratory that offers mutation screening of several genes. The Factor H gene (CFH) encodes the protein complement FACTOR H (HF1), which is a member of the alternative pathway of the complement cascade. Mutations in CFH have been found in persons with Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II. Screening is offered to persons with biopsy-proven DDD/MPGNII; we will also screen other complement-related genes. Testing turn-around time is three months. sequencing. Testing for CFH is performed by bidirectional Sending a Sample 1. There is NO charge for this service. (We will NOT cover the costs of phlebotomy or shipping.) 2. Send a purple-top tube with 8-10 cc blood clearly labeled with NAME, DATE OF BIRTH, and AGE. 3. For mutation screening of CFH, a renal biopsy must be consistent with the diagnosis of DDD/MPGNII at the electron microscopic level and by immunofluorescence. To inquire about other CFZ-related diseases, please contact one of the persons listed below. 4. For other tests of the complement cascade, please contact one of the persons listed below. 5. Include the name, e-mail and telephone number of a contact person (physician, genetic counselor). 6. Mail overnight delivery at ROOM TEMPERATURE to: Richard Smith, MD, Department of Otolaryngology, University of Iowa, 200 Hawkins Drive - 21151 PFP, Iowa City, IA 52242. Do NOT send samples for Saturday delivery. 7. DNA can be sent instead of whole blood. Note: If the requested clinical information is NOT received and a patient consent form is NOT signed, mutation screening will NOT be done. Each sample is evaluated on a case-percase basis and additional testing might be pursued if appropriate. We follow guidelines proposed by the American College of Medical Genetics and do not offer carrier testing for autosomal recessive deafness in minors. Contacts: [email protected], [email protected], [email protected], [email protected].